We are live on ! Find out more
SBC

SBC Medical Group
SBC

45 hedge funds and large institutions have $103M invested in SBC Medical Group in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,400% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 1

114% more funds holding

Funds holding: 21 → 45 (+24)

85% more capital invested

Capital invested by funds: $55.4M → $103M (+$47.3M)

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

37.12% more ownership

Funds ownership: 45.36% → 82.48% (+37%)

Holders
45
Holders Change
+24
Holders Change %
+114.29%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
5
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$4.3M
2
CCM
Context Capital Management
California
+$4.3M
3
AA
AQR Arbitrage
Connecticut
+$3.79M
4
TCA
Taconic Capital Advisors
New York
+$3.67M
5
SIA
Schechter Investment Advisors
Michigan
+$3.63M

Top Sellers

Rank Fund Capital Flow
1
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$1.2M
2
SRCM
Sage Rock Capital Management
New York
-$153K
3
PCM
Prelude Capital Management
New York
-$67.7K
4
CSS
Cubist Systematic Strategies
Connecticut
-$53.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Marshall Wace
26
Marshall Wace
United Kingdom
$1.53M – – –
PCM
27
Prelude Capital Management
New York
$1.49M -$67.7K -6,693 -4%
SFM
28
Spartan Fund Management
Canada
$1.37M +$1.35M +133,444 New
Deutsche Bank
29
Deutsche Bank
Germany
$1.24M +$1.23M +121,521 New
DWM
30
Dakota Wealth Management
Florida
$730K +$598K +59,100 +473%
FTCM
31
Fir Tree Capital Management
New York
$533K +$526K +51,997 New
WC
32
Wealthspring Capital
New York
$476K +$472K +46,700 New
CM
33
Crestline Management
Texas
$410K +$405K +40,000 New
WRBC
34
W.R. Berkley Corp
Connecticut
$357K – – –
WA
35
Whitebox Advisors
Minnesota
$357K +$354K +35,000 New
Millennium Management
36
Millennium Management
New York
$245K +$243K +24,000 New
WAM
37
Warberg Asset Management
Illinois
$186K – – –
VF
38
Virtu Financial
New York
$171K +$169K +16,701 New
CSS
39
Cubist Systematic Strategies
Connecticut
$150K -$53.1K -5,246 -26%
RCM
40
Robinson Capital Management
Michigan
$118K – – –
CCM
41
Condor Capital Management
New Jersey
$117K +$116K +11,500 New
SMA
42
Sage Mountain Advisors
Georgia
$117K +$116K +11,500 New
GCL
43
Glazer Capital LLC
New York
$106K +$105K +10,424 New
CS
44
Clear Street
New York
$29K +$28.5K +2,820 New
UBS Group
45
UBS Group
Switzerland
$1.02K +$1.01K +100 New
Parallax Volatility Advisers
46
Parallax Volatility Advisers
California
– -$1.2M -120,200 Closed
1
2

SBC Hedge Fund Activity: Q4 2022 in Review

45 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in SBC Medical Group (SBC) for Q4 2022, worth a combined $103M — up 85% from $55.4M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new SBC positions and 1 closed out — a net gain of 24 holders — while 5 added to existing stakes and 3 trimmed.

The largest buyer was Bank of Montreal, opening a new position worth an estimated $4.3M. The largest seller was Parallax Volatility Advisers, exiting entirely with an estimated $1.2M sold.

  • 45 institutional investors held SBC Medical Group (SBC) as of Q4 2022, up from 21 in Q3 2022.
  • Funds reported $103M of SBC Medical Group stock for Q4 2022, up 85% quarter-over-quarter.
  • 25 funds opened new SBC Medical Group positions in Q4 2022 and 1 closed out, a net change of +24 holders.
  • The largest SBC Medical Group buyer in Q4 2022 was Bank of Montreal, an estimated $4.3M added.
  • The largest SBC Medical Group seller in Q4 2022 was Parallax Volatility Advisers, an estimated $1.2M sold.

Based on aggregated 13F filings for Q4 2022.